Commensal microbiota associated with anti-PD-1 efficacy in metastatic melanoma patients

被引：0
|
作者：
Matson, Vyara [1 ]
Fessler, Jessica [1 ]
Bao, Riyue [1 ]
Chongsuwat, Tara [1 ]
Zha, Yuanyuan [1 ]
Alegre, Maria-Luisa [1 ]
Luke, Jason [1 ]
Gajewski, Thomas [1 ]
机构：
[1] Univ Chicago, Chicago, IL 60637 USA
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2017年 / 5卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P394
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Fecal microbiota transplantation followed by anti-PD-1 treatment in patients with advanced melanoma.
    Miller, Wilson H.
    Routy, Bertrand
    Jamal, Rahima
    Ernst, D. Scott
    Logan, Diane
    Esfahani, Khashayar
    Belanger, Karl
    Elkrief, Arielle
    Lapointe, Rejean
    Thebault, Pamela
    Ponce, Mayra
    Parvathy, Seema Nair
    Messaoudene, Meriem
    Silverman, Micheal
    Maleki, Saman
    Lenehan, John Gordon
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [22] Ipilimumab versus ipilimumab plus anti-PD-1 for metastatic melanoma
    Li, Mengqian
    LANCET ONCOLOGY, 2021, 22 (08): : E342 - E342
  • [23] Anti-PD-1 antibodies in metastatic uveal melanoma: a treatment option?
    Bender, Carolin
    Enk, Alexander
    Gutzmer, Ralf
    Hassel, Jessica C.
    CANCER MEDICINE, 2017, 6 (07): : 1581 - 1586
  • [24] Anti-PD-1 approaches—important steps forward in metastatic melanoma
    Mina Razzak
    Nature Reviews Clinical Oncology, 2013, 10 (7) : 365 - 365
  • [25] The cessation of anti-PD-1 antibodies of complete responders in metastatic melanoma
    Ladwa, Rahul
    Atkinson, Victoria
    MELANOMA RESEARCH, 2017, 27 (02) : 168 - 170
  • [26] Antiepidermis autoantibodies induced by anti-PD-1 therapy in metastatic melanoma
    Brunet-Possenti, Florence
    Mignot, Sabine
    Deschamps, Lydia
    Descamps, Vincent
    MELANOMA RESEARCH, 2016, 26 (05) : 540 - 543
  • [27] Efficacy of combined hypofractionated radiotherapy and anti-PD-1 monotherapy in patients with melanoma.
    Roger, Anissa
    Finet, Adeline
    Boru, Blandine
    Mazeron, Jean-Jacques
    Otmezguine, Yves
    Blom, Astrid
    Longvert, Christine
    De Maleissye, Marie-Florence
    Beauchet, Alain
    Saiag, Philippe
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [28] Factors Influencing the Efficacy of Anti-PD-1 Therapy in Chinese Patients with Advanced Melanoma
    Zhao, Lingdi
    Yang, Yonghao
    Ma, Baozhen
    Li, Wei
    Li, Tiepeng
    Han, Lu
    Zhang, Yong
    Shang, Yi-Man
    Lin, Hongwei
    Gao, Quanli
    JOURNAL OF ONCOLOGY, 2019, 2019
  • [29] Germline Variation in PDCD1 Is Associated with Overall Survival in Patients with Metastatic Melanoma Treated with Anti-PD-1 Monotherapy
    de With, Mirjam
    Hurkmans, Daan P.
    Oomen-de Hoop, Esther
    Lalouti, Ayoub
    Bins, Sander
    El Bouazzaoui, Samira
    van Brakel, Mandy
    Debets, Reno
    Aerts, Joachim G. J. V.
    van Schaik, Ron H. N.
    Mathijssen, Ron H. J.
    van der Veldt, Astrid A. M.
    CANCERS, 2021, 13 (06) : 1 - 13
  • [30] Serum CD73 is a prognostic factor in patients with metastatic melanoma and is associated with response to anti-PD-1 therapy
    Turiello, Roberta
    Capone, Mariaelena
    Giannarelli, Diana
    Morretta, Elva
    Monti, Maria Chiara
    Madonna, Gabriele
    Mallardo, Domenico
    Festino, Lucia
    Azzaro, Rosa
    Levesque, Mitchell P.
    Imhof, Laurence
    Weide, Benjamin
    Amaral, Teresa
    Chevrier, Marc
    Sucker, Antje
    Rutkowski, Piotr
    Schadendorf, Dirk
    Lebbe, Celeste
    Luke, Jason John
    Wistuba-Hamprecht, Kilian
    Dummer, Reinhard
    Pinto, Aldo
    Morello, Silvana
    Ascierto, Paolo A.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (02)
12345